|
MechanismPeptide hydrolase inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Agrenvec SL
0 Patents (Medical) associated with Agrenvec SL
100 Deals associated with Agrenvec SL
100 Translational Medicine associated with Agrenvec SL